Antisera and other blood fractions300210 (Harmonized System 1992 for 6-digit)
2020 World Trade: $172B, Rnk 9 / 4613
2020 Top Exporter | Top Importer: $32.5B | $34.7B, Germany | United States
2020 Product Complexity: 1.36, Rnk 328 / 4783
2019 - 2020 Export Growth (CAGR): 15.2%, Rnk 298 / 4613
2018 Mean Tariff: 1.62%, Rnk 6334 / 6538
2020 Share of World Trade: 1.03%, Rnk 9 / 4613
Overview This page contains the latest trade data of Antisera and other blood fractions. In 2020, Antisera and other blood fractions were the world's 9th most traded product, with a total trade of $172B. Between 2019 and 2020 the exports of Antisera and other blood fractions grew by 15.2%, from $149B to $172B. Trade in Antisera and other blood fractions represent 1.03% of total world trade.
Antisera and other blood fractions are a part of Vaccines, blood, antisera, toxins and cultures.
Exports In 2020 the top exporters of Antisera and other blood fractions were Germany ($32.5B), Switzerland ($29.8B), United States ($24.8B), Ireland ($24B), and Belgium ($9.38B).
Imports In 2020 the top importers of Antisera and other blood fractions were United States ($34.7B), Germany ($22.9B), Switzerland ($11.5B), Netherlands ($10.4B), and Belgium ($8.52B).
Tariffs In 2018 the average tariff for Antisera and other blood fractions was 1.62%, making it the 6334th lowest tariff using the HS6 product classification.
Ranking Antisera and other blood fractions ranks 328th in the Product Complexity Index (PCI).
The following visualization shows the latest trends on Antisera and other blood fractions. Countries are shown based on data availability.
For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.
* Using January 2020 exchange rates when trade data is reported in local currency.
Trade By Country
Top Origin (2020): Germany, $32.5B
Top Destination (2020): United States, $34.7B
Antisera and other blood fractions are the world's 9th most traded product.
In 2020, the top exporters of Antisera and other blood fractions were Germany ($32.5B), Switzerland ($29.8B), United States ($24.8B), Ireland ($24B), and Belgium ($9.38B).
In 2020, the top importers of Antisera and other blood fractions were United States ($34.7B), Germany ($22.9B), Switzerland ($11.5B), Netherlands ($10.4B), and Belgium ($8.52B).
Trade by country
Top Origin Growth (2019 - 2020): Ireland, $6.24B
Top Destination Growth (2019 - 2020): Germany, $4.75B
Between 2019 and 2020, the exports of Antisera and other blood fractions grew the fastest in Ireland ($6.24B), Germany ($4.7B), South Korea ($2.74B), Belgium ($2.32B), and China ($2.25B).
Between 2019 and 2020, the fastest growing importers of Antisera and other blood fractions were Germany ($4.75B), United States ($3.65B), Belgium ($2.28B), Switzerland ($1.85B), and Japan ($1.15B).
Cumulative market share
This chart shows the evolution of the market concentration of exports of Antisera and other blood fractions.
In 2020, market concentration measured using Shannon Entropy, was 3.67. This means that most of the exports of Antisera and other blood fractions are explained by 12 countries.
TOP NET EXPORTER (2020): Ireland, $20.8B
TOP NET IMPORTER (2020): United States, $9.94B
This map shows which countries export or import more of Antisera and other blood fractions. Each country is colored based on the difference in exports and imports of Antisera and other blood fractions during 2020.
In 2020, the countries that had a largest trade value in exports than in imports of Antisera and other blood fractions were Ireland ($20.8B), Switzerland ($18.3B), Germany ($9.63B), South Korea ($3.76B), and Singapore ($2.17B).
In 2020, the countries that had a largest trade value in imports than in exports of Antisera and other blood fractions were United States ($9.94B), China ($4.37B), Japan ($4.27B), Canada ($3.91B), and France ($3.42B).
This visualization shows the countries that have an important ratio of their trade related to Antisera and other blood fractions. It is possible to select the main countries that export or import Antisera and other blood fractions in the world, or by continent, as well as select the measure of interest.
The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.
Have questions, comments, or concerns?
Send us an e-mail: [email protected]
v5.1.14 lamb